These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 37355690)
1. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids. Sebastian R; Jin K; Pavon N; Bansal R; Potter A; Song Y; Babu J; Gabriel R; Sun Y; Aronow B; Pak C Nat Commun; 2023 Jun; 14(1):3770. PubMed ID: 37355690 [TBL] [Abstract][Full Text] [Related]
2. Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived Pak C; Danko T; Mirabella VR; Wang J; Liu Y; Vangipuram M; Grieder S; Zhang X; Ward T; Huang YA; Jin K; Dexheimer P; Bardes E; Mitelpunkt A; Ma J; McLachlan M; Moore JC; Qu P; Purmann C; Dage JL; Swanson BJ; Urban AE; Aronow BJ; Pang ZP; Levinson DF; Wernig M; Südhof TC Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035170 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review. Castronovo P; Baccarin M; Ricciardello A; Picinelli C; Tomaiuolo P; Cucinotta F; Frittoli M; Lintas C; Sacco R; Persico AM Clin Genet; 2020 Jan; 97(1):125-137. PubMed ID: 30873608 [TBL] [Abstract][Full Text] [Related]
4. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models. Zeng L; Zhang P; Shi L; Yamamoto V; Lu W; Wang K PLoS One; 2013; 8(3):e59685. PubMed ID: 23536886 [TBL] [Abstract][Full Text] [Related]
5. Incomplete penetrance of NRXN1 deletions in families with schizophrenia. Todarello G; Feng N; Kolachana BS; Li C; Vakkalanka R; Bertolino A; Weinberger DR; Straub RE Schizophr Res; 2014 May; 155(1-3):1-7. PubMed ID: 24680031 [TBL] [Abstract][Full Text] [Related]
6. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes. Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527 [TBL] [Abstract][Full Text] [Related]
7. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560 [TBL] [Abstract][Full Text] [Related]
8. [Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays]. Wang L; Shi P; Ren H; Xue S; Kong X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1200-1204. PubMed ID: 36317203 [TBL] [Abstract][Full Text] [Related]
9. Precise Therapeutic Targeting of Distinct Fernando MB; Fan Y; Zhang Y; Kammourh S; Murphy AN; Ghorbani S; Onatzevitch R; Pero A; Padilla C; Flaherty EK; Prytkova IK; Cao L; Williams S; Fang G; Slesinger PA; Brennand KJ bioRxiv; 2023 Dec; ():. PubMed ID: 37961635 [TBL] [Abstract][Full Text] [Related]
13. Unraveling Mechanisms of Patient-Specific NRXN1 Mutations in Neuropsychiatric Diseases Using Human Induced Pluripotent Stem Cells. De Los Angeles A; Tunbridge EM Stem Cells Dev; 2020 Sep; 29(17):1142-1144. PubMed ID: 32122280 [TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of 17 NRXN1 deletions. Enggaard Hoeffding LK; Hansen T; Ingason A; Doung L; Thygesen JH; Møller RS; Tommerup N; Kirov G; Rujescu D; Larsen LA; Werge T Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):52-61. PubMed ID: 24339137 [TBL] [Abstract][Full Text] [Related]
15. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697 [TBL] [Abstract][Full Text] [Related]
16. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627 [TBL] [Abstract][Full Text] [Related]